Comprehension and data-sharing behavior of direct-to-consumer genetic test customers

Scott P. McGrath, Jason D Coleman, Lotfollah Najjar, Ann L Fruhling, Dhundy Raj Bastola

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Aim: The aim of this study was to evaluate current direct-to-consumer (DTC) genetic customers' ability to interpret and comprehend test results and to determine if honest brokers are needed. Method: One hundred and twenty-two customers of the DTC genetic testing company 23andMe were polled in an online survey. The subjects were asked about their personal test results and to interpret the results of two mock test cases (type 2 diabetes and multiple sclerosis), where results were translated into disease probability for an individual compared to the public. Results: When asked to evaluate the risk, 72.1% correctly assessed the first case and 77% were correct on the second case. Only 23.8% of those surveyed were able to interpret both cases correctly. χ2 and logistic regression were used to interpret the results. Participants who took the time to read the DTC test-provided supplemental material were 3.93 times (p = 0.040) more likely to correctly interpret the test results than those who did not. The odds for correctly interpreting the test cases were 3.289 times (p = 0.011) higher for those who made more than USD 50,000 than those who made less. Survey results were compared to the Health Information National Trends Survey (HINTS) phase 4 cycle 3 data to evaluate national trends. Conclusions: Most of the subjects were able to correctly interpret the test cases, yet a majority did not share their results with a health-care professional. As the market for DTC genetic testing grows, test comprehension will become more critical. Involving more health professionals in this process may be necessary to ensure proper interpretations.

Original languageEnglish (US)
Pages (from-to)116-124
Number of pages9
JournalPublic Health Genomics
Volume19
Issue number2
DOIs
StatePublished - Apr 1 2016

Fingerprint

Information Dissemination
Genetic Testing
Aptitude
Health
Type 2 Diabetes Mellitus
Multiple Sclerosis
Logistic Models
Delivery of Health Care
Surveys and Questionnaires
Direct-To-Consumer Screening and Testing

Keywords

  • Data-sharing behavior
  • Direct-to-consumer genetic test
  • Honest brokers
  • Risk comprehension

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Genetics(clinical)

Cite this

Comprehension and data-sharing behavior of direct-to-consumer genetic test customers. / McGrath, Scott P.; Coleman, Jason D; Najjar, Lotfollah; Fruhling, Ann L; Bastola, Dhundy Raj.

In: Public Health Genomics, Vol. 19, No. 2, 01.04.2016, p. 116-124.

Research output: Contribution to journalArticle

@article{f668ed3253074aa4927f5bfafdce2d40,
title = "Comprehension and data-sharing behavior of direct-to-consumer genetic test customers",
abstract = "Aim: The aim of this study was to evaluate current direct-to-consumer (DTC) genetic customers' ability to interpret and comprehend test results and to determine if honest brokers are needed. Method: One hundred and twenty-two customers of the DTC genetic testing company 23andMe were polled in an online survey. The subjects were asked about their personal test results and to interpret the results of two mock test cases (type 2 diabetes and multiple sclerosis), where results were translated into disease probability for an individual compared to the public. Results: When asked to evaluate the risk, 72.1{\%} correctly assessed the first case and 77{\%} were correct on the second case. Only 23.8{\%} of those surveyed were able to interpret both cases correctly. χ2 and logistic regression were used to interpret the results. Participants who took the time to read the DTC test-provided supplemental material were 3.93 times (p = 0.040) more likely to correctly interpret the test results than those who did not. The odds for correctly interpreting the test cases were 3.289 times (p = 0.011) higher for those who made more than USD 50,000 than those who made less. Survey results were compared to the Health Information National Trends Survey (HINTS) phase 4 cycle 3 data to evaluate national trends. Conclusions: Most of the subjects were able to correctly interpret the test cases, yet a majority did not share their results with a health-care professional. As the market for DTC genetic testing grows, test comprehension will become more critical. Involving more health professionals in this process may be necessary to ensure proper interpretations.",
keywords = "Data-sharing behavior, Direct-to-consumer genetic test, Honest brokers, Risk comprehension",
author = "McGrath, {Scott P.} and Coleman, {Jason D} and Lotfollah Najjar and Fruhling, {Ann L} and Bastola, {Dhundy Raj}",
year = "2016",
month = "4",
day = "1",
doi = "10.1159/000444477",
language = "English (US)",
volume = "19",
pages = "116--124",
journal = "Public Health Genomics",
issn = "1662-4246",
publisher = "S. Karger AG",
number = "2",

}

TY - JOUR

T1 - Comprehension and data-sharing behavior of direct-to-consumer genetic test customers

AU - McGrath, Scott P.

AU - Coleman, Jason D

AU - Najjar, Lotfollah

AU - Fruhling, Ann L

AU - Bastola, Dhundy Raj

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Aim: The aim of this study was to evaluate current direct-to-consumer (DTC) genetic customers' ability to interpret and comprehend test results and to determine if honest brokers are needed. Method: One hundred and twenty-two customers of the DTC genetic testing company 23andMe were polled in an online survey. The subjects were asked about their personal test results and to interpret the results of two mock test cases (type 2 diabetes and multiple sclerosis), where results were translated into disease probability for an individual compared to the public. Results: When asked to evaluate the risk, 72.1% correctly assessed the first case and 77% were correct on the second case. Only 23.8% of those surveyed were able to interpret both cases correctly. χ2 and logistic regression were used to interpret the results. Participants who took the time to read the DTC test-provided supplemental material were 3.93 times (p = 0.040) more likely to correctly interpret the test results than those who did not. The odds for correctly interpreting the test cases were 3.289 times (p = 0.011) higher for those who made more than USD 50,000 than those who made less. Survey results were compared to the Health Information National Trends Survey (HINTS) phase 4 cycle 3 data to evaluate national trends. Conclusions: Most of the subjects were able to correctly interpret the test cases, yet a majority did not share their results with a health-care professional. As the market for DTC genetic testing grows, test comprehension will become more critical. Involving more health professionals in this process may be necessary to ensure proper interpretations.

AB - Aim: The aim of this study was to evaluate current direct-to-consumer (DTC) genetic customers' ability to interpret and comprehend test results and to determine if honest brokers are needed. Method: One hundred and twenty-two customers of the DTC genetic testing company 23andMe were polled in an online survey. The subjects were asked about their personal test results and to interpret the results of two mock test cases (type 2 diabetes and multiple sclerosis), where results were translated into disease probability for an individual compared to the public. Results: When asked to evaluate the risk, 72.1% correctly assessed the first case and 77% were correct on the second case. Only 23.8% of those surveyed were able to interpret both cases correctly. χ2 and logistic regression were used to interpret the results. Participants who took the time to read the DTC test-provided supplemental material were 3.93 times (p = 0.040) more likely to correctly interpret the test results than those who did not. The odds for correctly interpreting the test cases were 3.289 times (p = 0.011) higher for those who made more than USD 50,000 than those who made less. Survey results were compared to the Health Information National Trends Survey (HINTS) phase 4 cycle 3 data to evaluate national trends. Conclusions: Most of the subjects were able to correctly interpret the test cases, yet a majority did not share their results with a health-care professional. As the market for DTC genetic testing grows, test comprehension will become more critical. Involving more health professionals in this process may be necessary to ensure proper interpretations.

KW - Data-sharing behavior

KW - Direct-to-consumer genetic test

KW - Honest brokers

KW - Risk comprehension

UR - http://www.scopus.com/inward/record.url?scp=84961218557&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961218557&partnerID=8YFLogxK

U2 - 10.1159/000444477

DO - 10.1159/000444477

M3 - Article

VL - 19

SP - 116

EP - 124

JO - Public Health Genomics

JF - Public Health Genomics

SN - 1662-4246

IS - 2

ER -